Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083859 · ClinicalTrials.gov registry record · NA
Digital Outreach Intervention for Lung Cancer Screening
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 26,998
- Enrollment target
NCT04083859 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 26,998 participants.
The verdict
NCT04083859, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 26,998 participants
- Enrollment target
Study Summary
mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.
Interventions
- OTHER mPATH-Lung
- OTHER Lung health video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,998 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04083859
The ClinicalTrials.gov registry entry for NCT04083859 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26,998 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which mPATH-Lung is the first listed.
NCT04083859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04083859 about?
NCT04083859 is a clinical study titled "Digital Outreach Intervention for Lung Cancer Screening". mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic rand...
What is the current status of trial NCT04083859?
This trial is currently completed. It is a NA study. The enrollment target is 26,998 participants. The study started on 2022-01-01. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT04083859?
The interventions under investigation include: mPATH-Lung (OTHER), Lung health video (OTHER).
Who is sponsoring clinical trial NCT04083859?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.